SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001437749-20-023976
Filing Date
2020-11-16
Accepted
2020-11-16 14:37:38
Documents
1
Group Members
FRANK G. PILKIEWICZ REVOCABLE TRUST DTD 10-17-2001MICHAEL B. DEGIDIO

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G caro20201113_sc13g.htm SC 13G 153267
  Complete submission text file 0001437749-20-023976.txt   154803
Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
Kintara Therapeutics, Inc. (Subject) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: SC 13G | Act: 34 | File No.: 005-87181 | Film No.: 201315718
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3 DAVENPORT DRIVE PRINCETON JUNCTION NJ 08550
Business Address
Pilkiewicz Carolyn (Filed by) CIK: 0001830372 (see all company filings)

Type: SC 13G